Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation

JACC: Cardiovascular Imaging

Volumn 7, Issue 1, 2014, Pages 1-11

  Neilan, Tomas G ^a,b   Mongeon, Francois Pierre ^a,c   Shah, Ravi V ^a,b   Coelho Filho, Otavio ^a,d   Abbasi, Siddique A ^a   Dodson, John A ^e   McMullan, Ciaran J ^e   Heydari, Bobak ^a   Michaud, Gregory F ^a   John, Roy M ^a   Blankstein, Ron ^a   Jerosch Herold, Michael ^e   Kwong, Raymond Y ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MONTREAL HEART INSTITUTE   (Canada)

^d UNIVERSITY OF CAMPINAS   (Brazil)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

cardiac magnetic resonance; myocardial fibrosis; T1 measurements

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIASTOLE; DISEASE ASSOCIATION; EXTRACELLULAR SPACE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT ATRIUM; HEART LEFT ATRIUM VOLUME; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART VOLUME; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYOCARDIAL EXTRACELLULAR VOLUME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PULMONARY VEIN ISOLATION; RECURRENCE RISK; RECURRENT DISEASE; VERY ELDERLY; ATRIAL FIBRILLATION; CARDIAC MUSCLE; CARDIOMYOPATHIES; CATHETER ABLATION; CINE MAGNETIC RESONANCE IMAGING; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FIBROSIS; HEART ATRIUM; PATHOLOGY; PATHOPHYSIOLOGY; PILOT STUDY; PROCEDURES; PULMONARY VEIN;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIAC VOLUME; CARDIOMYOPATHIES; CATHETER ABLATION; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; EXTRACELLULAR SPACE; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; PILOT PROJECTS; PROSPECTIVE STUDIES; PULMONARY VEINS; RECURRENCE;

EID: 84892546008     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2013.08.013     Document Type: Article

References (47)

1. D. Levy, M.G. Larson, R.S. Vasan, W.B. Kannel, and K.K. Ho The progression from hypertension to congestive heart failure JAMA 275 1996 1557 1562
2. K.T. Weber Cardiac interstitium in health and disease: the fibrillar collagen network J Am Coll Cardiol 13 1989 1637 1652
3. A. Frustaci, M. Caldarulo, A. Buffon, F. Bellocci, R. Fenici, and D. Melina Cardiac biopsy in patients with "primary" atrial fibrillation. Histologic evidence of occult myocardial diseases Chest 100 1991 303 306
4. L.H. Ling, P.M. Kistler, and A.H. Ellims et al. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction J Am Coll Cardiol 60 2012 2402 2408
5. J. Diez, R. Querejeta, B. Lopez, A. Gonzalez, M. Larman, and J.L. Martinez Ubago Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients Circulation 105 2002 2512 2517
6. R.J. Kim, D.S. Fieno, and T.B. Parrish et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1999 1992 2002
7. N. Mewton, C.Y. Liu, P. Croisille, D. Bluemke, and J.A. Lima Assessment of myocardial fibrosis with cardiovascular magnetic resonance J Am Coll Cardiol 57 2011 891 903
8. A. Rudolph, H. Abdel-Aty, and S. Bohl et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling J Am Coll Cardiol 53 2009 284 291
9. V.O. Puntmann, C. Jahnke, and R. Gebker et al. Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy Am J Cardiol 106 2010 1016 1022
10. C.G. Brilla, R.C. Funck, and H. Rupp Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease Circulation 102 2000 1388 1393
11. R. Querejeta, B. Lopez, and A. Gonzalez et al. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis Circulation 110 2004 1263 1268
12. M.A. Rossi Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans J Hypertens 16 1998 1031 1041
13. M. Jerosch-Herold, D.C. Sheridan, and J.D. Kushner et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy Am J Physiol Heart Circ Physiol 295 2008 H1234 H1242
14. C.S. Broberg, S.S. Chugh, C. Conklin, D.J. Sahn, and M. Jerosch-Herold Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease Circ Cardiovasc Imaging 3 2010 727 734
15. A.S. Flett, M.P. Hayward, and M.T. Ashworth et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans Circulation 122 2010 138 144
16. M. Ugander, A.J. Oki, and L.Y. Hsu et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology Eur Heart J 33 2012 1268 1278
17. L. Iles, H. Pfluger, and A. Phrommintikul et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping J Am Coll Cardiol 52 2008 1574 1580
18. T.C. Wong, K. Piehler, and C.G. Meier et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality Circulation 126 2012 1206 1216
19. O.R. Coelho-Filho, F.P. Mongeon, and R. Mitchell et al. The role of transcytolemmal water exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease Circ Cardiovasc Imaging 6 2013 134 141
20. A.V. Chobanian, G.L. Bakris, and H.R. Black et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572
21. D. Levy, S.B. Labib, K.M. Anderson, J.C. Christiansen, W.B. Kannel, and W.P. Castelli Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy Circulation 81 1990 815 820
22. F.P. Mongeon, M. Jerosch-Herold, O.R. Coelho-Filho, R. Blankstein, R.H. Falk, and R.Y. Kwong Quantification of extracellular matrix expansion by CMR in infiltrative heart disease J Am Coll Cardiol Img 5 2012 897 907
23. T.G. Neilan, O.R. Coelho-Filho, and R.V. Shah et al. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions J Am Coll Cardiol Img 6 2013 672 683
24. C.Y. Ho, S.A. Abbasi, and T.G. Neilan et al. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy Circ Cardiovasc Imaging 6 2013 415 422
25. J.G. Cleland, J.C. Daubert, and E. Erdmann et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
26. T.S. Tsang, B.J. Gersh, and C.P. Appleton et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women J Am Coll Cardiol 40 2002 1636 1644
27. S.M. Vaziri, M.G. Larson, E.J. Benjamin, and D. Levy Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study Circulation 89 1994 724 730
28. F. Kuwahara, H. Kai, and K. Tokuda et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats Circulation 106 2002 130 135
29. J.S. Shinbane, M.A. Wood, D.N. Jensen, K.A. Ellenbogen, A.P. Fitzpatrick, and M.M. Scheinman Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies J Am Coll Cardiol 29 1997 709 715
30. X. He, X. Gao, and L. Peng et al. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7 Circ Res 108 2011 164 175
31. M.F. Swartz, G.W. Fink, and M.F. Sarwar et al. Elevated pre-operative serum peptides for collagen i and iii synthesis result in post-surgical atrial fibrillation J Am Coll Cardiol 60 2012 1799 1806
32. B. Dahlof, R.B. Devereux, and S.E. Kjeldsen et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 2002 995 1003
33. D. Levy, R.J. Garrison, D.D. Savage, W.B. Kannel, and W.P. Castelli Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 322 1990 1561 1566
34. D.A. Bluemke, R.A. Kronmal, and J.A. Lima et al. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study J Am Coll Cardiol 52 2008 2148 2155
35. P. Anversa, R. Ricci, and G. Olivetti Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: a review J Am Coll Cardiol 7 1986 1140 1149
36. J.M. Gardin, A. Arnold, and J.S. Gottdiener et al. Left ventricular mass in the elderly. The Cardiovascular Health Study Hypertension 29 1997 1095 1103
37. A.C. Armstrong, S. Gidding, O. Gjesdal, C. Wu, D.A. Bluemke, and J.A. Lima LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice J Am Coll Cardiol Img 5 2012 837 848
38. R.M. Lang, M. Bierig, and R.B. Devereux et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
39. C.G. Missouris, S.M. Forbat, D.R. Singer, N.D. Markandu, R. Underwood, and G.A. MacGregor Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension J Hypertens 14 1996 1005 1010
40. A.M. Maceira, S.K. Prasad, M. Khan, and D.J. Pennell Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance J Cardiovasc Magn Reson 8 2006 417 426
41. D.R. Messroghli, A. Radjenovic, S. Kozerke, D.M. Higgins, M.U. Sivananthan, and J.P. Ridgway Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart Magn Reson Med 52 2004 141 146
42. J.J. Lee, S. Liu, and M.S. Nacif et al. Myocardial T1 and extracellular volume fraction mapping at 3 tesla J Cardiovasc Magn Reson 13 2011 75
43. P.I. Polimeni Extracellular space and ionic distribution in rat ventricle Am J Physiol 227 1974 676 683
44. C. Jellis, J. Wright, and D. Kennedy et al. Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy Circ Cardiovasc Imaging 4 2011 693 702
45. A.S. Flett, D.M. Sado, and G. Quarta et al. Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study Eur Heart J Cardiovasc Imaging 13 2012 819 826
46. M.P. Schneider, T.A. Hua, M. Bohm, K. Wachtell, S.E. Kjeldsen, and R.E. Schmieder Prevention of atrial fibrillation by renin-angiotensin system inhibition: a meta-analysis J Am Coll Cardiol 55 2012 2299 2307
47. S. Yusuf, K. Teo, and C. Anderson et al. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial Lancet 372 2008 1174 1183